14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 70 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMM.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Immutep Limited stock price ended at $0.455 on Friday, after gaining 4.60%.
(Updated on May 17, 2024)

Buy or Hold candidate since Apr 29, 2024 Gain 2.25% PDF

The Immutep Limited stock price gained 4.60% on the last trading day (Friday, 17th May 2024), rising from $0.435 to $0.455. During the last trading day the stock fluctuated 5.81% from a day low at $0.430 to a day high of $0.455. The price has fallen in 6 of the last 10 days but is still up by 4.6% over the past 2 weeks. Volume fell on the last day by -412 thousand shares and in total, 992 thousand shares were bought and sold for approximately $451.40 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.42% during the next 3 months and, with a 90% probability hold a price between $0.481 and $0.625 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMM.AX Signals & Forecast

The Immutep Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.452 and $0.411. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 07, 2024, and so far it has fallen -6.19%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Immutep Limited stock

Immutep Limited finds support from accumulated volume at $0.450 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0250 between high and low, or 5.81%. For the last week the stock has had daily average volatility of 4.60%.

Our recommended stop-loss: $0.433 (-4.92%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (IMM.AX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Immutep Limited to open at $0.447, and during the day (based on 14 day Average True Range), to move between $0.431 and $0.479, which gives a possible trading interval of +/-$0.0239 (+/-5.26%) up or down from last closing price. If Immutep Limited takes out the full calculated possible swing range there will be an estimated 10.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.460 (1.10%) than the support at $0.450 (1.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immutep Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immutep Limited stock to perform well in the short-term.

Current score: 3.687 Buy Candidate Unchanged

Predicted Opening Price for Immutep Limited of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$0.447 ( 1.83%) $0.455

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMM.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.472 3.66 %
R2 0.462 1.56 %
R1 0.456 0.267 %
Current price: 0.455
Support S1 0.437 -3.93 %
S2 0.431 -5.23 %
S3 0.422 -7.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.485 6.59 %
R2 0.470 3.30 %
R1 0.460 1.10 %
Current price 0.455
Support S1 0.450 -1.10%
S2 0.420 -7.69%
S3 0.400 -12.09%

FAQ

What is the symbol for Immutep Limited Stock and on which exchange is it traded?
The symbol for Immutep Limited is IMM.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Immutep Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immutep Limited stock to perform well in the short-term.

How to buy Immutep Limited Stock?
Immutep Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immutep Limited Stock.

What's the current price of Immutep Limited Stock?
As of the end of day on the May 17, 2024, the price of an Immutep Limited (IMM.AX) share was $0.455.

What is the 52-week high and low for Immutep Limited Stock?
The 52-week high for Immutep Limited Stock is $0.485 and the 52-week low is $0.260.

What is the market capitalization of Immutep Limited Stock?
As of the May 17, 2024, the market capitalization of Immutep Limited is 540.918M.

When is the next earnings date for Immutep Limited?
The upcoming earnings date for Immutep Limited is Jul 28, 2024.
Click to get the best stock tips daily for free!

About Immutep Limited

Immutep Limited Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, wh... IMM.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT